Clinical Trial

Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke

Study acronym: MERIT
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Normal saline (0.9% sodium chloride), a classical crystalloid solution, is widely used to maintain fluid balance, volume resuscitation and dilute drugs during clinical practice. However, the chloride concentration of normal saline (154mmol/L) is much higher than human plasma, and a large amount of infusion may lead to iatrogenic hyperchloremia in ICU patients. In contrast, the concentrations of Multiple electrolytes II is more similar to those of plasma and is considered to be a better fluid choice than normal saline.
Trial Details
NCT Number NCT06374823
Lead Sponsor Capital Medical University
Conditions Critical Care, Hyperchloremia, Hemorrhagic Stroke
Enrollment 342 participants
Start Date 2024-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-04-19